BIOMAT Database Logo BIOMAT Database Logo

The comparative studies on factor XIII of newborn infants obtained by three methods; clot solubility, immunological and fluorescent assays. 1976

K Yamada, and A Shirahata, and T Meguro

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Yamada, and A Shirahata, and T Meguro
Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.
November 2016, Laboratory medicine,
K Yamada, and A Shirahata, and T Meguro
[Studies on the relationship between factor XIII activity and fibrin clot solubility test by urea and monochloroacetic acid (author's transl)].
December 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
K Yamada, and A Shirahata, and T Meguro
Immunological studies of coagulation factor XIII.
October 1973, The Journal of clinical investigation,
K Yamada, and A Shirahata, and T Meguro
[Immunological studies on factor XIII and FSF-binding globulin].
February 1974, Blut,
K Yamada, and A Shirahata, and T Meguro
Comparative studies on blood coagulation factor XIII.
May 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Yamada, and A Shirahata, and T Meguro
Comparative studies on tissue transglutaminase and factor XIII.
December 1972, Annals of the New York Academy of Sciences,
K Yamada, and A Shirahata, and T Meguro
[Comparative evaluation of factor XIII determination methods].
October 1974, Rinsho byori. The Japanese journal of clinical pathology,
K Yamada, and A Shirahata, and T Meguro
Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.
April 1970, British journal of haematology,
K Yamada, and A Shirahata, and T Meguro
Immunological studies of newborn infants with hyperbilirubinemia.
June 1981, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
K Yamada, and A Shirahata, and T Meguro
The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography.
July 2004, Anesthesia and analgesia,
Copied contents to your clipboard!